Friday 27th May 2022 |
Text too small? |
- the Company completed a 100 to 1 share consolidation in November 2021. As result of the consolidation, and after taking account of rounding of entitlements, the number of shares on issue in Ascension reduced from 1,914,888,105 to 19,148,828.
- there were no changes in the board of directors.
The focus of the Board going forward is to identify a suitable business opportunity to invest in and/or acquire through a reverse takeover transaction. Currently, there are no initiatives being investigated, but the Company will provide the market with any updates as to material developments in due course.
The financial result for the Company for the year ended 31 March 2022 is a loss after taxation of NZ$171,171, which is largely made up of the directors’ fees, NZX listing costs, and legal and accounting costs.
No comments yet
MWE - Suspension of Trading and Delisting
EBOS welcomes finalisation of First PWA
CVT - AMENDED: Bank covenant waiver and trading update
Gentrack Annual Report 2024
December 20th Morning Report
Rua Bioscience announces launch of new products in the UK
TEM - Appointment to the Board of Directors
December 19th Morning Report
RAD - Radius Care Announces On-market Share Buyback Programme
MCY - New wind farm propels MCY renewables commitment to $1b